16 Phase 2 clinical data showed that Resmetirom treatment resulted in a significant reduction in hepatic fat in patients with NASH, 17 and supported its advancement into Phase 3 clinical development (Figure 1)
Our national high-tech enterprise designation recognizes our innovative approaches to product development and quality control, including advanced storage methodologies that maximize product stability
Here is everything we know about TRIUMPH-1, what we expect from the data, and why this trial matters
With their diverse array of pumps and transporters, astrocytes are capable of delivering beneficial substances, including ions, neurotransmitters and metabolites, while also producing or releasing detrimental molecules, such as reactive oxygen and nitrogen species
He added that Circana plans to continue expanding the marketplace with additional partners to meet evolving retailer and consumer demands
klaim nya mencerahkan, dan betul